Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 3
2009 1
2010 5
2011 2
2012 5
2013 3
2014 3
2015 7
2016 9
2017 4
2018 14
2019 5
2020 4
2021 15
2022 7
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Harrison SA, Bashir MR, Guy CD, Zhou R, Moylan CA, Frias JP, Alkhouri N, Bansal MB, Baum S, Neuschwander-Tetri BA, Taub R, Moussa SE. Harrison SA, et al. Among authors: moylan ca. Lancet. 2019 Nov 30;394(10213):2012-2024. doi: 10.1016/S0140-6736(19)32517-6. Epub 2019 Nov 11. Lancet. 2019. PMID: 31727409 Clinical Trial.
REPLY.
Wegermann K, Suzuki A, Mavis AM, Abdelmalek MF, Diehl AM, Moylan CA. Wegermann K, et al. Among authors: moylan ca. Hepatology. 2021 Apr;73(4):1625. doi: 10.1002/hep.31593. Hepatology. 2021. PMID: 33040372 No abstract available.
Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction.
Salah HM, Pandey A, Soloveva A, Abdelmalek MF, Diehl AM, Moylan CA, Wegermann K, Rao VN, Hernandez AF, Tedford RJ, Parikh KS, Mentz RJ, McGarrah RW, Fudim M. Salah HM, et al. Among authors: moylan ca. JACC Basic Transl Sci. 2021 Nov 22;6(11):918-932. doi: 10.1016/j.jacbts.2021.07.010. eCollection 2021 Nov. JACC Basic Transl Sci. 2021. PMID: 34869957 Free PMC article. Review.
Updates in nonalcoholic fatty liver disease.
Wungjiranirun M, Wong N, Jou J, Moylan CA. Wungjiranirun M, et al. Among authors: moylan ca. Clin Liver Dis (Hoboken). 2023 Nov 17;22(5):157-161. doi: 10.1097/CLD.0000000000000085. eCollection 2023 Nov. Clin Liver Dis (Hoboken). 2023. PMID: 38026121 Free PMC article. No abstract available.
Tackling Nonalcoholic Fatty Liver Disease: Three Targeted Populations.
Wegermann K, Suzuki A, Mavis AM, Abdelmalek MF, Diehl AM, Moylan CA. Wegermann K, et al. Among authors: moylan ca. Hepatology. 2021 Mar;73(3):1199-1206. doi: 10.1002/hep.31533. Epub 2021 Feb 10. Hepatology. 2021. PMID: 32865242 Review. No abstract available.
Disease pathways and molecular mechanisms of nonalcoholic steatohepatitis.
Wegermann K, Diehl AM, Moylan CA. Wegermann K, et al. Among authors: moylan ca. Clin Liver Dis (Hoboken). 2018 Apr 20;11(4):87-91. doi: 10.1002/cld.709. eCollection 2018 Apr. Clin Liver Dis (Hoboken). 2018. PMID: 30992796 Free PMC article. Review. No abstract available.
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study.
Bowlus CL, Eksteen B, Cheung AC, Thorburn D, Moylan CA, Pockros PJ, Forman LM, Dorenbaum A, Hirschfield GM, Kennedy C, Jaecklin T, McKibben A, Chien E, Baek M, Vig P, Levy C. Bowlus CL, et al. Among authors: moylan ca. Hepatol Commun. 2023 May 15;7(6):e0153. doi: 10.1097/HC9.0000000000000153. eCollection 2023 Jun 1. Hepatol Commun. 2023. PMID: 37184523 Free PMC article.
81 results